Migraine
Not recruitingStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
- Disease:Migraine
- Substances:Lu Ag09222
Poland- Participants:18–64 years
- Substances:Lu Ag09222
- Sponsor:H. Lundbeck A/S
Rare diseases
Investigational molecules
Locations
Back to Poland36 clinical trials in Sochaczew, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on psoriatic arthritis and plaque psoriasis, evaluating new therapeutic approaches and treatment effectiveness. Multiple trials are investigating innovative medications for managing these chronic inflammatory conditions.
Research includes assessment of novel biologics and comparative studies between different treatment options.
Innovative research on respiratory diseases including studies on influenza vaccines, RSV infections, and COPD management. These trials aim to enhance prevention and treatment strategies for respiratory conditions.
Focus on both preventive measures and therapeutic interventions for respiratory illnesses.
Studies addressing migraine prevention and Alzheimer's-related conditions. Research includes evaluation of new treatments for chronic pain conditions and agitation in dementia patients.
Comprehensive approach to addressing both symptoms and underlying conditions.
Advanced studies in cardiovascular disease and heart failure management, investigating new therapeutic approaches and combination treatments to improve patient outcomes.
Focus on innovative therapies and prevention strategies for heart-related conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.